NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

Agilent Technologies, Inc. A | NYSE

$181.16 -$0.32 | -0.18%
TREND SIGNAL:Signal available — unlock to view |2026-10-09

Company Overview:

Market Cap: $51.23B
Trailing PE: 35.7x
FWD PE *: 27.6x
Payout Ratio (TTM): 19.9%
52-Week Range: $108.35 - $182.99

* Forward PE is based on street estimates.

10 Year A Performance Metrics:

Total Return (with DRIP): 347.3% (16.16% CAGR)
Total Return (no DRIP): 333.0% (15.78% CAGR)
Share Price: 319.2% (15.41% CAGR)
Yield on Cost (with DRIP): 2.52%
Total Invested: $10,000
Total Value (with DRIP): $44,728
Total Return $ (with DRIP): $34,728
Dividend Increase: 93.2% (6.97% CAGR)
Dividend Yield (FWD): 0.56% ($1.02)
A 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
A Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
A Price CAGR:1Y: 26.51%2Y: 17.49%5Y: 2.84%10Y: 15.41%
A Dividend Charts
A - Dividends
A Dividend CAGR:1Y: 2.82%2Y: 3.95%5Y: 5.62%10Y: 8.29%
A - Dividend Payout Ratio
A Dividend Payout Ratio CAGR:1Y: -5.88%2Y: -9.18%5Y: -2.30%10Y: -3.97%
A - Dividend to Free Cash Flow Ratio
A Dividend to FCF Ratio CAGR:1Y: -40.17%2Y: -6.82%5Y: -4.96%10Y: -2.79%
Build Custom Charts
A - Chart 1
A - Chart 2
A - Chart 3

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

A Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

A - Revenue
A Revenue CAGR:1Y: 8.06%2Y: 9.09%5Y: 3.44%10Y: 6.05%
A - Earnings Per Share (EPS)
A EPS CAGR:1Y: 8.47%2Y: 14.87%5Y: 8.28%10Y: 12.91%
A - Net Income
🔓 See the full chart40% off right now · 7-day free trial
A Net Income CAGR:1Y: 7.74%2Y: 13.30%5Y: 6.52%10Y: 11.31%
A - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
A EBITDA CAGR:1Y: 15.67%2Y: 12.22%5Y: 4.53%10Y: 9.83%
A - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
A Free Cash Flow CAGR:1Y: 69.50%2Y: 10.43%5Y: 9.49%10Y: 9.95%
A - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
A Free Cash Flow / Share CAGR:1Y: 71.30%2Y: 11.98%5Y: 11.07%10Y: 11.52%
A - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
A Operating Income CAGR:1Y: 23.33%2Y: 15.47%5Y: 5.73%10Y: 11.76%
A - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
A Gross Profit CAGR:1Y: 17.34%2Y: 10.40%5Y: 4.11%10Y: 6.75%
A - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
A Shares Outstanding CAGR:1Y: -0.70%2Y: -1.38%5Y: -1.55%10Y: -1.46%
A - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
A Share Buybacks CAGR:1Y: -8.24%2Y: -63.49%5Y: -7.15%10Y: -1.85%
A - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
A Stock-Based Comp CAGR:1Y: 0.00%2Y: 6.90%5Y: 7.78%10Y: 11.27%
A - Expenses
🔓 See the full chart40% off right now · 7-day free trial
A Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
A - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
A - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
A - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
A - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
A - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
A - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
A - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
A Revenue CAGR:1Y: 8.06%2Y: 9.09%5Y: 3.44%10Y: 6.05%
A - Revenue by Region
🔓 See the full chart40% off right now · 7-day free trial
A Revenue CAGR:1Y: 8.06%2Y: 9.09%5Y: 3.44%10Y: 6.05%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

A - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
A Actual Revenue CAGR:1Y: 8.06%2Y: 9.09%5Y: 3.44%10Y: 6.05%
A - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
A Actual EPS CAGR:1Y: 8.47%2Y: 14.87%5Y: 8.28%10Y: 12.91%
A - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
A Actual Net Income CAGR:1Y: 7.74%2Y: 13.30%5Y: 6.52%10Y: 11.31%
A - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
A Actual EBITDA CAGR:1Y: 15.67%2Y: 12.22%5Y: 4.53%10Y: 9.83%

Ratios, Profit Margins & Return on Capital:

A - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
A Net Profit Margin CAGR:1Y: -0.26%2Y: 3.87%5Y: 2.98%10Y: 4.96%
A - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
A Gross Profit Margin CAGR:1Y: 5.50%2Y: 1.19%5Y: 0.65%10Y: 0.67%
A - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
A Price to Earnings CAGR:1Y: 11.11%2Y: -13.78%5Y: -9.27%10Y: -1.48%
A - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
A Price To Sales Ratio CAGR:1Y: 10.36%2Y: -10.58%5Y: -6.63%10Y: 3.38%
A - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
A Return on Capital Employed CAGR:1Y: 9.14%2Y: -0.87%5Y: -0.16%10Y: 5.54%
A - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
A Return on Invested Capital CAGR:1Y: -4.99%2Y: 1.86%5Y: -2.77%10Y: 3.37%

Compare stocks side-by-side

A Dividends Info:

Annual Dividend: $1.02
Forward Yield: 0.56%
Ex-Dividend Date: 2026-10-06
Lifetime Dividends / Share: $11.22

A Dividend History: Dates, Payments & Yield list

Below is a schedule of all A dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
10/06/202610/08/2026$0.2550.6%0.61%$168.17
06/30/202607/02/2026$0.2550.77%0.78%$130.69
03/31/202604/02/2026$0.2550.89%0.88%$115.48
01/06/202601/08/2026$0.2550.69%0.7%$145.76
09/30/202510/02/2025$0.2480.77%0.72%$138.70
07/01/202507/03/2025$0.2480.82%0.82%$121.38
04/01/202504/03/2025$0.2480.87%0.9%$109.67
12/31/202401/02/2025$0.2480.74%0.74%$133.43
10/01/202410/03/2024$0.2360.64%0.65%$144.55
07/02/202407/04/2024$0.2360.75%0.7%$134.16
04/01/202404/03/2024$0.2360.65%0.66%$143.73
12/29/202301/01/2024$0.2360.68%0.73%$129.78
10/02/202310/04/2023$0.2250.81%0.81%$111.67
06/30/202307/03/2023$0.2250.75%0.75%$119.32
04/03/202304/05/2023$0.2250.65%0.65%$138.09
12/30/202201/25/2023$0.2250.6%0.58%$155.76
10/03/202210/26/2022$0.2100.66%0.61%$137.69
07/01/202207/27/2022$0.2100.7%0.66%$127.71
04/04/202204/27/2022$0.2100.62%0.71%$117.68
01/03/202201/26/2022$0.2100.54%0.63%$133.51
10/04/202110/27/2021$0.1940.51%0.5%$155.26
07/02/202107/28/2021$0.1940.52%0.51%$151.46
04/05/202104/28/2021$0.1940.6%0.58%$134.80
01/04/202101/27/2021$0.1940.65%0.65%$118.80
10/05/202010/28/2020$0.1800.7%0.71%$101.66
06/29/202007/22/2020$0.1800.82%0.75%$96.35
03/30/202004/22/2020$0.1800.99%0.96%$75.17
12/30/201901/22/2020$0.1800.85%0.8%$90.13
09/30/201910/23/2019$0.1640.86%0.87%$74.98
07/01/201907/24/2019$0.1640.87%0.94%$69.58
04/01/201904/24/2019$0.1640.8%0.87%$75.79
12/28/201801/23/2019$0.1640.99%0.92%$71.65
10/01/201810/24/2018$0.1490.84%0.97%$61.13
07/02/201807/25/2018$0.1490.97%0.9%$65.96
04/02/201804/25/2018$0.1490.93%0.91%$65.80
12/29/201701/24/2018$0.1490.89%0.81%$73.58
10/02/201710/25/2017$0.1320.81%0.78%$67.39
06/29/201707/26/2017$0.1320.9%0.88%$59.72
03/31/201704/26/2017$0.1321%0.96%$54.83
12/29/201601/25/2017$0.1321.16%1.09%$48.41
09/30/201610/26/2016$0.1150.98%1.06%$43.37
06/30/201607/27/2016$0.1151.04%0.97%$47.26
04/01/201604/27/2016$0.1151.14%1.11%$41.58
12/31/201501/27/2016$0.1151.1%1.24%$37.05
09/25/201510/21/2015$0.1001.16%1.11%$35.90
06/26/201507/22/2015$0.1001%0.99%$40.33
03/27/201504/22/2015$0.1000.97%0.94%$42.71
01/02/201501/28/2015$0.1000.99%1.05%$38.00
09/26/201410/22/2014$0.0940.93%1%$37.95
06/27/201407/23/2014$0.0940.92%0.92%$41.11
04/09/201404/23/2014$0.0940.95%0.96%$39.35
12/27/201301/22/2014$0.0940.92%0.87%$43.58
09/27/201310/23/2013$0.0860.93%0.95%$36.23
06/28/201307/24/2013$0.0861.12%1.03%$33.45
03/28/201304/24/2013$0.0861.14%1.12%$30.65
12/27/201201/23/2013$0.0720.98%0.9%$31.69
09/28/201210/24/2012$0.0721.04%1.12%$25.64
06/29/201207/25/2012$0.0721.02%1.11%$25.85
03/30/201204/25/2012$0.0720.9%0.97%$29.46
11/01/200611/03/2006$1.47124.14%24.98%$23.56

Projected Future Returns & Dividends for A

Based on past 10-year performance, here are A growth metrics:

Share price CAGR of +15.41%
Dividend CAGR of +8.33%

Using A CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

A (DRIP)A - No DRIP
Current Price$181.16$181.16
Start Shares55.2055.20
Start Value$10,000$10,000
  
After 10 years:
Final Share Count57.6355.20
Dividends Payment$0.57$0.57
Annual Dividends$131$125
Yield on cost1.31%1.25%
Share Price$759.35$759.35
Total Dividends$851$829
Final Value$43,759$42,744

Estimated Future Value + Dividends - A

NOTE: Above numbers are our estimate based on A's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

Agilent Technologies, Inc. (A) had its IPO on 1999-11-18, and is traded on NYSE stock exchange.

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

A website: https://www.agilent.com


Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF Model — A

Value from:
Pay up to today
—
vs current price $181.16
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →